Tomio Wada

582 total citations
12 papers, 438 citations indexed

About

Tomio Wada is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Tomio Wada has authored 12 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Tomio Wada's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (4 papers). Tomio Wada is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (4 papers). Tomio Wada collaborates with scholars based in Japan. Tomio Wada's co-authors include Hiroki Koyama, Takeshi Iwanaga, Goro Kōsaki, T. Terasawa, Yukitoshi AOKI, Yukio Nishizawa, Akira Wada, T. Yamamoto, Masahiro Watatani and Masayuki Yasutomi and has published in prestigious journals such as Cancer, Breast Cancer Research and Treatment and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

Tomio Wada

11 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomio Wada Japan 8 163 153 121 113 75 12 438
Yukitoshi AOKI Japan 6 143 0.9× 151 1.0× 119 1.0× 76 0.7× 52 0.7× 12 386
Harald Lass Austria 8 150 0.9× 61 0.4× 139 1.1× 75 0.7× 54 0.7× 13 514
Kennedy Bj United States 12 115 0.7× 54 0.4× 83 0.7× 57 0.5× 107 1.4× 36 563
T.B. Johannesen Norway 11 142 0.9× 34 0.2× 98 0.8× 51 0.5× 91 1.2× 17 472
Jacques Olivier Bay France 12 201 1.2× 43 0.3× 56 0.5× 80 0.7× 116 1.5× 30 474
A. Robinson United Kingdom 12 393 2.4× 58 0.4× 68 0.6× 332 2.9× 80 1.1× 35 764
J. Mazurka Canada 10 120 0.7× 23 0.2× 177 1.5× 45 0.4× 167 2.2× 15 488
Denise Barbuto United States 17 90 0.6× 50 0.3× 477 3.9× 78 0.7× 68 0.9× 20 857
Samuel Kopel United States 8 197 1.2× 179 1.2× 39 0.3× 45 0.4× 155 2.1× 14 628
Haiqing Ma China 12 145 0.9× 64 0.4× 27 0.2× 150 1.3× 188 2.5× 13 518

Countries citing papers authored by Tomio Wada

Since Specialization
Citations

This map shows the geographic impact of Tomio Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomio Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomio Wada more than expected).

Fields of papers citing papers by Tomio Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomio Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomio Wada. The network helps show where Tomio Wada may publish in the future.

Co-authorship network of co-authors of Tomio Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomio Wada. A scholar is included among the top collaborators of Tomio Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomio Wada. Tomio Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
3.
Wada, Tomio, et al.. (1994). Conventional dose CAF therapy versus low dose adriamycin therapy in the treatment of advanced breast cancer. Breast Cancer. 1(1). 51–56. 2 indexed citations
4.
Watatani, Masahiro, et al.. (1993). Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy. Breast Cancer Research and Treatment. 28(3). 231–239. 18 indexed citations
5.
Watatani, Masahiro, et al.. (1993). Adrenal metastasis from carcinoma of the colon and rectum: A report of three cases. Surgery Today. 23(5). 444–448. 32 indexed citations
6.
Shrestha, Prashanta, Kazuto Yamada, Tomio Wada, et al.. (1992). Proliferating cell nuclear antigen in breast lesions: Correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 421(3). 193–202. 31 indexed citations
7.
Wada, Tomio, et al.. (1991). Immunohistochemical expression of epidermal growth factor receptor in benign and malignant lesions of the breast.. ACTA HISTOCHEMICA ET CYTOCHEMICA. 24(5). 449–455. 3 indexed citations
8.
Koyama, Hiroki, Yukio Nishizawa, Tomio Wada, et al.. (1985). Intra-arterial infusion chemotherapy as an induction therapy in multidisciplinary treatment for locally advanced breast cancer. A long-term follow-up study. Cancer. 56(4). 725–729. 18 indexed citations
9.
Wada, Tomio, Hiroki Koyama, & T. Terasawa. (1981). Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: A sequential trial. Breast Cancer Research and Treatment. 1(1). 53–58. 7 indexed citations
10.
Koyama, Hiroki, Tomio Wada, Yoshikazu Takahashi, et al.. (1980). Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer. Cancer. 46(11). 2373–2379. 23 indexed citations
11.
Koyama, Hiroki, Tomio Wada, Yukio Nishizawa, et al.. (1977). Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 39(4). 1403–1409. 266 indexed citations
12.
Koyama, Hiroki, Tomio Wada, Yoshikazu Takahashi, et al.. (1975). Intra-arterial infusion chemotherapy as a preoperative treatment of locally advanced breast cancer. Cancer. 36(5). 1603–1612. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026